GO ID | GO:0005509 |
Ontology | MF |
GO Term | calcium ion binding |
Definition | Interacting selectively and non-covalently with calcium ions (Ca2+). |
Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
---|---|---|---|---|
ESYT2 |
extended synaptotagmin-like protein 2 |
57488 |
A0FGR8 |
chr7: 158,730,995-158,830,253 |
CIB4 |
calcium and integrin binding family member 4 |
130106 |
A0PJX0 |
chr2: 26,581,202-26,641,368 |
MASP2 |
mannan-binding lectin serine peptidase 2 |
10747 |
O00187 |
chr1: 11,026,523-11,047,233 |
MATN2 |
matrilin 2 |
4147 |
O00339 |
chr8: 97,868,840-98,036,716 |
EML1 |
echinoderm microtubule associated protein like 1 |
2009 |
O00423 |
chr14: 99,737,693-99,942,060 |
NDUFAB1 |
NADH:ubiquinone oxidoreductase subunit AB1 |
4706 |
O14561 |
chr16: 23,581,002-23,596,356 |
NCAN |
neurocan |
1463 |
O14594 |
chr19: 19,211,973-19,252,233 |
PRRG1 |
proline rich Gla (G-carboxyglutamic acid) 1 |
5638 |
O14668 |
chrX: 37,349,275-37,457,295 |
PCDH17 |
protocadherin 17 |
27253 |
O14917 |
chr13: 57,631,810-57,729,311 |
CLGN |
calmegin |
1047 |
O14967 |
chr4: 140,388,455-140,427,968 |
PLSCR1 |
phospholipid scramblase 1 |
5359 |
O15162 |
chr3: 146,515,180-146,544,864 |
CETN3 |
centrin 3 |
1070 |
O15182 |
chr5: 90,392,261-90,409,786 |
DHH |
desert hedgehog |
50846 |
O43323 |
chr12: 49,089,421-49,094,819 |
ACTN4 |
actinin, alpha 4 |
81 |
O43707 |
chr19: 38,647,649-38,731,583 |
CALU |
calumenin |
813 |
O43852 |
chr7: 128,739,292-128,771,807 |
EDIL3 |
EGF-like repeats and discoidin I-like domains 3 |
10085 |
O43854 |
chr5: 83,940,554-84,384,793 |
NOL3 |
nucleolar protein 3 |
8996 |
O60936 |
chr16: 67,170,154-67,175,735 |
EFCAB14 |
EF-hand calcium binding domain 14 |
9813 |
O75071 |
chr1: 46,675,159-46,719,064 |
RAB11FIP3 |
RAB11 family interacting protein 3 (class II) |
9727 |
O75154 |
chr16: 425,619-523,011 |
PDCD6 |
programmed cell death 6 |
10016 |
O75340 |
chr5: 271,621-353,856 |
SLC25A12 |
solute carrier family 25 (aspartate/glutamate carrier), member 12 |
8604 |
O75746 |
chr2: 171,784,370-171,999,859 |
SLIT2 |
slit guidance ligand 2 |
9353 |
O94813 |
chr4: 20,253,260-20,620,561 |
CLSTN1 |
calsyntenin 1 |
22883 |
O94985 |
chr1: 9,729,026-9,824,526 |
LETM1 |
leucine zipper-EF-hand containing transmembrane protein 1 |
3954 |
O95202 |
chr4: 1,811,479-1,856,247 |
GUCA1C |
guanylate cyclase activator 1C |
9626 |
O95843 |
chr3: 108,907,792-108,953,895 |
EFEMP2 |
EGF containing fibulin-like extracellular matrix protein 2 |
30008 |
O95967 |
chr11: 65,866,441-65,873,592 |
F2 |
coagulation factor II (thrombin) |
2147 |
P00734 |
chr11: 46,719,180-46,739,506 |
C1R |
complement component 1, r subcomponent |
715 |
P00736 |
chr12: 7,080,209-7,092,607 |
LDLR |
low density lipoprotein receptor |
3949 |
P01130 |
chr19: 11,089,362-11,133,816 |
CRP |
C-reactive protein, pentraxin-related |
1401 |
P02741 |
chr1: 159,712,289-159,714,589 |
APCS |
amyloid P component, serum |
325 |
P02743 |
chr1: 159,587,825-159,588,865 |
BGLAP |
bone gamma-carboxyglutamate (gla) protein |
632 |
P02818 |
chr1: 156,241,962-156,243,321 |
MMP1 |
matrix metallopeptidase 1 |
4312 |
P03956 |
chr11: 102,789,920-102,798,160 |
ANXA1 |
annexin A1 |
301 |
P04083 |
chr9: 73,151,757-73,170,393 |
S100B |
S100 calcium binding protein B |
6285 |
P04271 |
chr21: 46,598,962-46,605,208 |
S100A8 |
S100 calcium binding protein A8 |
6279 |
P05109 |
chr1: 153,390,032-153,391,188 |
CLEC3B |
C-type lectin domain family 3 member B |
7123 |
P05452 |
chr3: 45,001,548-45,036,071 |
S100A9 |
S100 calcium binding protein A9 |
6280 |
P06702 |
chr1: 153,357,854-153,361,027 |
S100A6 |
S100 calcium binding protein A6 |
6277 |
P06703 |
chr1: 153,534,599-153,536,244 |
ANXA2 |
annexin A2 |
302 |
P07355 |
chr15: 60,347,134-60,402,883 |
THBS1 |
thrombospondin 1 |
7057 |
P07996 |
chr15: 39,581,079-39,599,466 |
ANXA6 |
annexin A6 |
309 |
P08133 |
chr5: 151,100,712-151,157,882 |
MGP |
matrix Gla protein |
4256 |
P08493 |
chr12: 14,881,181-14,885,926 |
ANXA5 |
annexin A5 |
308 |
P08758 |
chr4: 121,667,955-121,697,113 |
MMP10 |
matrix metallopeptidase 10 |
4319 |
P09238 |
chr11: 102,770,503-102,780,628 |
SPARC |
secreted protein, acidic, cysteine-rich (osteonectin) |
6678 |
P09486 |
chr5: 151,661,096-151,687,165 |
ANXA4 |
annexin A4 |
307 |
P09525 |
chr2: 69,644,425-69,827,100 |
C1S |
complement component 1, s subcomponent |
716 |
P09871 |
chr12: 6,988,259-7,071,032 |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
3309 |
P11021 |
chr9: 125,234,853-125,241,330 |
MBL2 |
mannose-binding lectin (protein C) 2, soluble |
4153 |
P11226 |
chr10: 52,765,380-52,771,700 |
ANXA3 |
annexin A3 |
306 |
P12429 |
chr4: 78,551,519-78,610,451 |
ACTN1 |
actinin, alpha 1 |
87 |
P12814 |
chr14: 68,874,143-68,979,440 |
MYL4 |
myosin light chain 4 |
4635 |
P12829 |
chr17: 47,200,446-47,223,679 |
BMP1 |
bone morphogenetic protein 1 |
649 |
P13497 |
chr8: 22,164,736-22,212,326 |
VCAN |
versican |
1462 |
P13611 |
chr5: 83,471,465-83,582,303 |
TPT1 |
tumor protein, translationally-controlled 1 |
7178 |
P13693 |
chr13: 45,333,471-45,341,370 |
LCP1 |
lymphocyte cytosolic protein 1 (L-plastin) |
3936 |
P13796 |
chr13: 46,125,920-46,211,871 |
PRKCSH |
protein kinase C substrate 80K-H |
5589 |
P14314 |
chr19: 11,435,288-11,450,968 |
NID1 |
nidogen 1 |
4811 |
P14543 |
chr1: 235,975,830-236,065,162 |
PLA2G2A |
phospholipase A2 group IIA |
5320 |
P14555 |
chr1: 19,975,431-19,980,416 |
HSP90B1 |
heat shock protein 90kDa beta family member 1 |
7184 |
P14625 |
chr12: 103,930,107-103,953,645 |
MYL6B |
myosin light chain 6B |
140465 |
P14649 |
chr12: 56,152,256-56,159,647 |
ARSA |
arylsulfatase A |
410 |
P15289 |
chr22: 50,622,754-50,628,173 |
ATP2A2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
488 |
P16615 |
chr12: 110,280,756-110,351,093 |
PAM |
peptidylglycine alpha-amidating monooxygenase |
5066 |
P19021 |
chr5: 102,753,981-103,031,105 |
CDH2 |
cadherin 2, type 1, N-cadherin (neuronal) |
1000 |
P19022 |
chr18: 27,950,966-28,177,446 |
MYL12A |
myosin light chain 12A |
10627 |
P19105 |
chr18: 3,247,481-3,256,236 |
CAPN3 |
calpain 3 |
825 |
P20807 |
chr15: 42,359,500-42,412,318 |
SYT1 |
synaptotagmin 1 |
6857 |
P21579 |
chr12: 78,863,993-79,452,008 |
ENPP1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
5167 |
P22413 |
chr6: 131,808,016-131,895,155 |
CALB2 |
calbindin 2 |
794 |
P22676 |
chr16: 71,358,713-71,390,438 |
MMP8 |
matrix metallopeptidase 8 |
4317 |
P22894 |
chr11: 102,711,795-102,727,050 |
FBLN1 |
fibulin 1 |
2192 |
P23142 |
chr22: 45,502,238-45,601,135 |
MMP11 |
matrix metallopeptidase 11 |
4320 |
P24347 |
chr22: 23,768,226-23,784,316 |
MYL9 |
myosin light chain 9 |
10398 |
P24844 |
chr20: 36,541,484-36,551,447 |
S100P |
S100 calcium binding protein P |
6286 |
P25815 |
chr4: 6,693,069-6,697,170 |
S100A4 |
S100 calcium binding protein A4 |
6275 |
P26447 |
chr1: 153,543,613-153,550,136 |
PON1 |
paraoxonase 1 |
5444 |
P27169 |
chr7: 95,297,676-95,324,707 |
CALR |
calreticulin |
811 |
P27797 |
chr19: 12,938,578-12,944,489 |
CANX |
calnexin |
821 |
P27824 |
chr5: 179,678,628-179,730,925 |
S100A2 |
S100 calcium binding protein A2 |
6273 |
P29034 |
chr1: 153,561,108-153,567,890 |
SRI |
sorcin |
6717 |
P30626 |
chr7: 88,205,118-88,226,993 |
S100A7 |
S100 calcium binding protein A7 |
6278 |
P31151 |
chr1: 153,457,744-153,460,701 |
S100A11 |
S100 calcium binding protein A11 |
6282 |
P31949 |
chr1: 152,032,506-152,047,907 |
CDH5 |
cadherin 5, type 2 (vascular endothelium) |
1003 |
P33151 |
chr16: 66,366,622-66,404,786 |
MAN1A1 |
mannosidase, alpha, class 1A, member 1 |
4121 |
P33908 |
chr6: 119,177,209-119,349,761 |
PRSS3 |
protease, serine 3 |
5646 |
P35030 |
chr9: 33,750,466-33,799,231 |
THBS4 |
thrombospondin 4 |
7060 |
P35443 |
chr5: 79,991,311-80,083,287 |
FBN1 |
fibrillin 1 |
2200 |
P35555 |
chr15: 48,408,306-48,645,849 |
FBN2 |
fibrillin 2 |
2201 |
P35556 |
chr5: 128,257,909-128,659,185 |
ACTN2 |
actinin, alpha 2 |
88 |
P35609 |
chr1: 236,686,454-236,764,631 |
HPCAL1 |
hippocalcin-like 1 |
3241 |
P37235 |
chr2: 10,302,889-10,427,617 |
SNCA |
synuclein alpha |
6622 |
P37840 |
chr4: 89,724,099-89,838,315 |
PLA2G5 |
phospholipase A2 group V |
5322 |
P39877 |
chr1: 20,028,179-20,091,190 |
EPS15 |
epidermal growth factor receptor pathway substrate 15 |
2060 |
P42566 |
chr1: 51,354,263-51,519,328 |
GPD2 |
glycerol-3-phosphate dehydrogenase 2 |
2820 |
P43304 |
chr2: 156,435,290-156,613,735 |
NOTCH1 |
notch 1 |
4851 |
P46531 |
chr9: 136,494,444-136,545,862 |
IQGAP1 |
IQ motif containing GTPase activating protein 1 |
8826 |
P46940 |
chr15: 90,388,218-90,502,243 |
PLA2G4A |
phospholipase A2 group IVA |
5321 |
P47712 |
chr1: 186,828,953-186,988,981 |
CD97 |
adhesion G protein-coupled receptor E5 |
976 |
P48960 |
chr19: 14,380,501-14,408,725 |
COMP |
cartilage oligomeric matrix protein |
1311 |
P49747 |
chr19: 18,782,773-18,791,314 |
MMP14 |
matrix metallopeptidase 14 |
4323 |
P50281 |
chr14: 22,836,557-22,849,027 |
ANXA11 |
annexin A11 |
311 |
P50995 |
chr10: 80,150,889-80,205,572 |
PLCD1 |
phospholipase C delta 1 |
5333 |
P51178 |
chr3: 38,007,496-38,029,762 |
MMP15 |
matrix metallopeptidase 15 |
4324 |
P51511 |
chr16: 58,025,566-58,046,901 |
MMP16 |
matrix metallopeptidase 16 |
4325 |
P51512 |
chr8: 88,032,009-88,328,025 |
CDH6 |
cadherin 6, type 2, K-cadherin (fetal kidney) |
1004 |
P55285 |
chr5: 31,193,750-31,329,146 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
1009 |
P55287 |
chr16: 64,943,753-65,126,112 |
CDH12 |
cadherin 12, type 2 (N-cadherin 2) |
1010 |
P55289 |
chr5: 21,750,673-22,853,622 |
CDH13 |
cadherin 13 |
1012 |
P55290 |
chr16: 82,626,803-83,800,640 |
CDH15 |
cadherin 15, type 1, M-cadherin (myotubule) |
1013 |
P55291 |
chr16: 89,171,767-89,195,492 |
TPD52 |
tumor protein D52 |
7163 |
P55327 |
chr8: 80,034,745-80,231,232 |
MYL6 |
myosin light chain 6 |
4637 |
P60660 |
chr12: 56,158,161-56,163,496 |
S100A10 |
S100 calcium binding protein A10 |
6281 |
P60903 |
chr1: 151,982,915-151,994,390 |
NCALD |
neurocalcin delta |
83988 |
P61601 |
chr8: 101,686,543-102,124,907 |
CALM2 |
calmodulin 2 |
805 |
P62158 |
chr2: 47,160,082-47,176,601 |
NCS1 |
neuronal calcium sensor 1 |
23413 |
P62166 |
chr9: 130,172,578-130,237,304 |
TPM4 |
tropomyosin 4 |
7171 |
P67936 |
chr19: 16,067,021-16,103,005 |
ADAM8 |
ADAM metallopeptidase domain 8 |
101 |
P78325 |
chr10: 133,262,403-133,276,868 |
JAG1 |
jagged 1 |
182 |
P78504 |
chr20: 10,637,684-10,674,107 |
NUCB2 |
nucleobindin 2 |
4925 |
P80303 |
chr11: 17,208,153-17,349,974 |
DLK1 |
delta-like 1 homolog (Drosophila) |
8788 |
P80370 |
chr14: 100,725,705-100,738,224 |
CRB1 |
crumbs family member 1, photoreceptor morphogenesis associated |
23418 |
P82279 |
chr1: 197,268,204-197,478,455 |
FBLN2 |
fibulin 2 |
2199 |
P98095 |
chr3: 13,549,131-13,638,422 |
VLDLR |
very low density lipoprotein receptor |
7436 |
P98155 |
chr9: 2,621,834-2,660,053 |
HSPG2 |
heparan sulfate proteoglycan 2 |
3339 |
P98160 |
chr1: 21,822,245-21,937,297 |
LRP2 |
LDL receptor related protein 2 |
4036 |
P98164 |
chr2: 169,127,109-169,362,685 |
MYL7 |
myosin light chain 7 |
58498 |
Q01449 |
chr7: 44,138,864-44,141,332 |
MYL5 |
myosin light chain 5 |
4636 |
Q02045 |
chr4: 673,580-682,033 |
DSC2 |
desmocollin 2 |
1824 |
Q02487 |
chr18: 31,058,840-31,102,415 |
NUCB1 |
nucleobindin 1 |
4924 |
Q02818 |
chr19: 48,900,050-48,923,372 |
DST |
dystonin |
667 |
Q03001 |
chr6: 56,457,987-56,954,628 |
NOTCH2 |
notch 2 |
4853 |
Q04721 |
chr1: 119,911,553-120,069,626 |
PPP2R3A |
protein phosphatase 2 regulatory subunit B'', alpha |
5523 |
Q06190 |
chr3: 135,965,673-136,147,891 |
PCDH1 |
protocadherin 1 |
5097 |
Q08174 |
chr5: 141,853,111-141,879,246 |
PPP3CA |
protein phosphatase 3, catalytic subunit, alpha isozyme |
5530 |
Q08209 |
chr4: 101,023,409-101,348,278 |
TBC1D8B |
TBC1 domain family member 8B |
54885 |
Q0IIM8 |
chrX: 106,802,680-106,876,145 |
ASPH |
aspartate beta-hydroxylase |
444 |
Q12797 |
chr8: 61,500,556-61,714,640 |
EFEMP1 |
EGF containing fibulin-like extracellular matrix protein 1 |
2202 |
Q12805 |
chr2: 55,865,967-55,924,139 |
FSTL1 |
follistatin like 1 |
11167 |
Q12841 |
chr3: 120,392,293-120,451,253 |
CDH17 |
cadherin 17, LI cadherin (liver-intestine) |
1015 |
Q12864 |
chr8: 94,127,171-94,217,303 |
CBLB |
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
868 |
Q13191 |
chr3: 105,655,461-105,869,552 |
MMRN1 |
multimerin 1 |
22915 |
Q13201 |
chr4: 89,879,532-89,954,629 |
PKD2 |
polycystic kidney disease 2 (autosomal dominant) |
5311 |
Q13563 |
chr4: 88,007,668-88,077,777 |
ENPP2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
5168 |
Q13822 |
chr8: 119,557,086-119,673,453 |
NID2 |
nidogen 2 |
22795 |
Q14112 |
chr14: 52,004,803-52,069,228 |
DAG1 |
dystroglycan 1 |
1605 |
Q14118 |
chr3: 49,468,703-49,535,618 |
DSG2 |
desmoglein 2 |
1829 |
Q14126 |
chr18: 31,498,043-31,549,008 |
ADGRE1 |
adhesion G protein-coupled receptor E1 |
2015 |
Q14246 |
chr19: 6,887,566-6,940,459 |
RCN2 |
reticulocalbin 2 |
5955 |
Q14257 |
chr15: 76,931,619-76,954,392 |
GAS6 |
growth arrest specific 6 |
2621 |
Q14393 |
chr13: 113,820,549-113,864,067 |
SPARCL1 |
SPARC like 1 |
8404 |
Q14515 |
chr4: 87,473,335-87,531,061 |
FAT1 |
FAT atypical cadherin 1 |
2195 |
Q14517 |
chr4: 186,587,783-186,726,722 |
ITPR2 |
inositol 1,4,5-trisphosphate receptor, type 2 |
3709 |
Q14571 |
chr12: 26,336,515-26,833,198 |
ITPR3 |
inositol 1,4,5-trisphosphate receptor, type 3 |
3710 |
Q14573 |
chr6: 33,620,365-33,696,574 |
ITPR1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
3708 |
Q14643 |
chr3: 4,493,348-4,847,840 |
PLS1 |
plastin 1 |
5357 |
Q14651 |
chr3: 142,596,387-142,713,664 |
MELK |
maternal embryonic leucine zipper kinase |
9833 |
Q14680 |
chr9: 36,572,862-36,677,683 |
LTBP1 |
latent transforming growth factor beta binding protein 1 |
4052 |
Q14766 |
chr2: 32,946,972-33,399,509 |
RCN1 |
reticulocalbin 1 |
5954 |
Q15293 |
chr11: 31,812,391-32,105,755 |
RYR3 |
ryanodine receptor 3 |
6263 |
Q15413 |
chr15: 33,310,945-33,866,121 |
RGN |
regucalcin |
9104 |
Q15493 |
chrX: 47,078,355-47,093,314 |
ITSN1 |
intersectin 1 |
6453 |
Q15811 |
chr21: 33,642,400-33,899,861 |
CACNA1E |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
777 |
Q15878 |
chr1: 181,413,102-181,808,084 |
AOC3 |
amine oxidase, copper containing 3 |
8639 |
Q16853 |
chr17: 42,851,184-42,858,130 |
PGS1 |
phosphatidylglycerophosphate synthase 1 |
9489 |
Q32NB8 |
chr17: 78,378,640-78,425,114 |
GNPTAB |
N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits |
79158 |
Q3T906 |
chr12: 101,745,497-101,830,938 |
EYS |
eyes shut homolog (Drosophila) |
346007 |
Q5T1H1 |
chr6: 63,719,980-65,707,225 |
EFCAB2 |
EF-hand calcium binding domain 2 |
84288 |
Q5VUJ9 |
chr1: 244,969,705-245,127,164 |
TBC1D9B |
TBC1 domain family member 9B |
23061 |
Q66K14 |
chr5: 179,862,066-179,907,859 |
MCTP1 |
multiple C2 domains, transmembrane 1 |
79772 |
Q6DN14 |
chr5: 94,703,741-95,284,575 |
CRELD2 |
cysteine rich with EGF-like domains 2 |
79174 |
Q6UXH1 |
chr22: 49,918,167-49,927,540 |
CCBE1 |
collagen and calcium binding EGF domains 1 |
147372 |
Q6UXH8 |
chr18: 59,430,940-59,697,380 |
PAMR1 |
peptidase domain containing associated with muscle regeneration 1 |
25891 |
Q6UXH9 |
chr11: 35,431,823-35,530,300 |
TBC1D9 |
TBC1 domain family member 9 |
23158 |
Q6ZT07 |
chr4: 140,620,765-140,756,120 |
FBN3 |
fibrillin 3 |
84467 |
Q75N90 |
chr19: 8,065,402-8,149,846 |
LPCAT2 |
lysophosphatidylcholine acyltransferase 2 |
54947 |
Q7L5N7 |
chr16: 55,508,998-55,586,670 |
RASGRP2 |
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
10235 |
Q7LDG7 |
chr11: 64,726,911-64,745,456 |
NOTCH2NL |
notch 2 N-terminal like |
388677 |
Q7Z3S9 |
chr1: 146,146,203-146,229,026 |
SPATA21 |
spermatogenesis associated 21 |
374955 |
Q7Z572 |
chr1: 16,387,117-16,437,424 |
NECAB2 |
N-terminal EF-hand calcium binding protein 2 |
54550 |
Q7Z6G3 |
chr16: 83,968,632-84,002,776 |
S100A7A |
S100 calcium binding protein A7A |
338324 |
Q86SG5 |
chr1: 153,416,524-153,423,225 |
C2CD5 |
C2 calcium-dependent domain containing 5 |
9847 |
Q86YS7 |
chr12: 22,448,583-22,544,546 |
SULF2 |
sulfatase 2 |
55959 |
Q8IWU5 |
chr20: 47,656,348-47,786,616 |
SULF1 |
sulfatase 1 |
23213 |
Q8IWU6 |
chr8: 69,466,624-69,660,915 |
SCUBE1 |
signal peptide, CUB domain, EGF-like 1 |
80274 |
Q8IWY4 |
chr22: 43,197,283-43,343,388 |
SCUBE3 |
signal peptide, CUB domain, EGF-like 3 |
222663 |
Q8IX30 |
chr6: 35,214,419-35,253,079 |
FAM20C |
family with sequence similarity 20 member C |
56975 |
Q8IXL6 |
chr7: 192,969-260,745 |
MICU2 |
mitochondrial calcium uptake 2 |
221154 |
Q8IYU8 |
chr13: 21,492,691-21,604,214 |
RASEF |
RAS and EF-hand domain containing |
158158 |
Q8IZ41 |
chr9: 82,979,585-83,063,177 |
NIN |
ninein |
51199 |
Q8N4C6 |
chr14: 50,719,763-50,831,121 |
EFCAB3 |
EF-hand calcium binding domain 3 |
146779 |
Q8N7B9 |
chr17: 62,343,941-62,416,479 |
USP32 |
ubiquitin specific peptidase 32 |
84669 |
Q8NFA0 |
chr17: 60,179,094-60,422,470 |
REPS2 |
RALBP1 associated Eps domain containing 2 |
9185 |
Q8NFH8 |
chrX: 16,946,691-17,153,280 |
DNER |
delta/notch like EGF repeat containing |
92737 |
Q8NFT8 |
chr2: 229,357,629-229,714,558 |
MCFD2 |
multiple coagulation factor deficiency 2 |
90411 |
Q8NI22 |
chr2: 46,901,870-46,941,855 |
PCDH19 |
protocadherin 19 |
57526 |
Q8TAB3 |
chrX: 100,291,644-100,410,273 |
SYTL5 |
synaptotagmin like 5 |
94122 |
Q8TDW5 |
chrX: 38,006,582-38,128,819 |
FAT3 |
FAT atypical cadherin 3 |
120114 |
Q8TDW7 |
chr11: 92,352,096-92,896,470 |
STAB2 |
stabilin 2 |
55576 |
Q8WWQ8 |
chr12: 103,587,273-103,766,727 |
GPR98 |
adhesion G protein-coupled receptor V1 |
84059 |
Q8WXG9 |
chr5: 90,529,344-91,164,437 |
TTN |
titin |
7273 |
Q8WZ42 |
chr2: 178,525,989-178,830,802 |
SPOCK2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
9806 |
Q92563 |
chr10: 72,059,035-72,089,032 |
EDEM1 |
ER degradation enhancer, mannosidase alpha-like 1 |
9695 |
Q92611 |
chr3: 5,187,646-5,219,957 |
RYR2 |
ryanodine receptor 2 (cardiac) |
6262 |
Q92736 |
chr1: 237,042,205-237,833,988 |
CCDC47 |
coiled-coil domain containing 47 |
57003 |
Q96A33 |
chr17: 63,745,250-63,776,351 |
FKBP10 |
FK506 binding protein 10 |
60681 |
Q96AY3 |
chr17: 41,812,680-41,823,217 |
EFHD2 |
EF-hand domain family member D2 |
79180 |
Q96C19 |
chr1: 15,409,895-15,430,343 |
SYTL4 |
synaptotagmin like 4 |
94121 |
Q96C24 |
chrX: 100,674,491-100,732,123 |
REPS1 |
RALBP1 associated Eps domain containing 1 |
85021 |
Q96D71 |
chr6: 138,903,493-138,988,261 |
VWCE |
von Willebrand factor C and EGF domains |
220001 |
Q96DN2 |
chr11: 61,258,286-61,295,424 |
S100A16 |
S100 calcium binding protein A16 |
140576 |
Q96FQ6 |
chr1: 153,606,886-153,613,145 |
CALML4 |
calmodulin like 4 |
91860 |
Q96GE6 |
chr15: 68,190,705-68,206,110 |
PPP3R2 |
protein phosphatase 3 regulatory subunit B, beta |
5535 |
Q96LZ3 |
chr9: 101,591,615-101,595,021 |
NECAB3 |
N-terminal EF-hand calcium binding protein 3 |
63941 |
Q96P71 |
chr20: 33,657,087-33,674,463 |
NOX5 |
NADPH oxidase, EF-hand calcium binding domain 5 |
79400 |
Q96PH1 |
chr15: 68,930,525-69,062,743 |
NELL2 |
neural EGFL like 2 |
4753 |
Q99435 |
chr12: 44,508,275-44,921,848 |
MMP19 |
matrix metallopeptidase 19 |
4327 |
Q99542 |
chr12: 55,835,433-55,842,966 |
S100A13 |
S100 calcium binding protein A13 |
6284 |
Q99584 |
chr1: 153,618,787-153,631,360 |
CHP1 |
calcineurin-like EF-hand protein 1 |
11261 |
Q99653 |
chr15: 41,230,839-41,281,890 |
CIB1 |
calcium and integrin binding 1 |
10519 |
Q99828 |
chr15: 90,229,975-90,234,047 |
EGFL8 |
EGF-like-domain, multiple 8 |
80864 |
Q99944 |
chr6: 32,164,583-32,168,281 |
SPOCK3 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
50859 |
Q9BQ16 |
chr4: 166,733,384-167,234,796 |
AIF1L |
allograft inflammatory factor 1-like |
83543 |
Q9BQI0 |
chr9: 131,096,476-131,123,152 |
SDF4 |
stromal cell derived factor 4 |
51150 |
Q9BRK5 |
chr1: 1,216,908-1,232,031 |
EFCAB11 |
EF-hand calcium binding domain 11 |
90141 |
Q9BUY7 |
chr14: 89,794,669-89,954,777 |
SLC25A23 |
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23 |
79085 |
Q9BV35 |
chr19: 6,436,079-6,465,203 |
CDHR2 |
cadherin related family member 2 |
54825 |
Q9BYE9 |
chr5: 176,542,511-176,595,974 |
PCDH11Y |
protocadherin 11 Y-linked |
83259 |
Q9BZA8 |
chrY: 5,000,226-5,742,224 |
PLA2G12A |
phospholipase A2 group XIIA |
81579 |
Q9BZM1 |
chr4: 109,709,989-109,730,077 |
EDEM3 |
ER degradation enhancer, mannosidase alpha-like 3 |
80267 |
Q9BZQ6 |
chr1: 184,690,231-184,754,913 |
PCDHAC1 |
protocadherin alpha subfamily C, 1 |
56135 |
Q9H158 |
chr5: 140,926,369-141,012,344 |
EHD4 |
EH domain containing 4 |
30844 |
Q9H223 |
chr15: 41,895,939-41,972,578 |
TTYH1 |
tweety family member 1 |
57348 |
Q9H313 |
chr19: 54,415,219-54,436,900 |
SMOC2 |
SPARC related modular calcium binding 2 |
64094 |
Q9H3U7 |
chr6: 168,441,151-168,673,445 |
CLSTN2 |
calsyntenin 2 |
64084 |
Q9H4D0 |
chr3: 139,935,185-140,577,397 |
EFCAB1 |
EF-hand calcium binding domain 1 |
79645 |
Q9HAE3 |
chr8: 48,710,789-48,735,311 |
ADGRL3 |
adhesion G protein-coupled receptor L3 |
23284 |
Q9HAR2 |
chr4: 61,201,258-62,078,335 |
PCDH9 |
protocadherin 9 |
5101 |
Q9HC56 |
chr13: 66,302,834-67,230,445 |
SLC24A3 |
solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 |
57419 |
Q9HC58 |
chr20: 19,212,646-19,722,937 |
SYTL2 |
synaptotagmin like 2 |
54843 |
Q9HCH5 |
chr11: 85,694,224-85,811,159 |
PCDH18 |
protocadherin 18 |
54510 |
Q9HCL0 |
chr4: 137,518,918-137,532,494 |
CD248 |
CD248 molecule, endosialin |
57124 |
Q9HCU0 |
chr11: 66,314,487-66,317,044 |
MMP25 |
matrix metallopeptidase 25 |
64386 |
Q9NPA2 |
chr16: 3,046,681-3,060,726 |
CD93 |
CD93 molecule |
22918 |
Q9NPY3 |
chr20: 23,079,349-23,086,340 |
PLCB1 |
phospholipase C beta 1 |
23236 |
Q9NQ66 |
chr20: 8,077,251-8,968,360 |
CRTAC1 |
cartilage acidic protein 1 |
55118 |
Q9NQ79 |
chr10: 97,865,000-98,030,828 |
MAN1C1 |
mannosidase, alpha, class 1C, member 1 |
57134 |
Q9NR34 |
chr1: 25,617,468-25,786,207 |
DLL4 |
delta-like 4 (Drosophila) |
54567 |
Q9NR61 |
chr15: 40,929,340-40,939,072 |
DUOX2 |
dual oxidase 2 |
50506 |
Q9NRD8 |
chr15: 45,092,650-45,114,344 |
DUOX1 |
dual oxidase 1 |
53905 |
Q9NRD9 |
chr15: 45,129,933-45,165,576 |
PLSCR4 |
phospholipid scramblase 4 |
57088 |
Q9NRQ2 |
chr3: 146,192,339-146,251,179 |
LTBP3 |
latent transforming growth factor beta binding protein 3 |
4054 |
Q9NS15 |
chr11: 65,538,805-65,558,930 |
KCNIP2 |
Kv channel interacting protein 2 |
30819 |
Q9NS61 |
chr10: 101,825,974-101,843,920 |
FKBP14 |
FK506 binding protein 14 |
55033 |
Q9NWM8 |
chr7: 30,010,587-30,026,684 |
STAB1 |
stabilin 1 |
23166 |
Q9NY15 |
chr3: 52,495,338-52,524,495 |
CELSR3 |
cadherin, EGF LAG seven-pass G-type receptor 3 |
1951 |
Q9NYQ7 |
chr3: 48,636,469-48,662,915 |
ITSN2 |
intersectin 2 |
50618 |
Q9NZM3 |
chr2: 24,202,864-24,360,714 |
EHD3 |
EH domain containing 3 |
30845 |
Q9NZN3 |
chr2: 31,234,337-31,269,447 |
SEPN1 |
selenoprotein N, 1 |
57190 |
Q9NZV5 |
chr1: 25,800,176-25,818,224 |
DSPP |
dentin sialophosphoprotein |
1834 |
Q9NZW4 |
chr4: 87,608,529-87,616,910 |
STIM2 |
stromal interaction molecule 2 |
57620 |
Q9P246 |
chr4: 26,857,678-27,025,381 |
PCDH10 |
protocadherin 10 |
57575 |
Q9P2E7 |
chr4: 133,149,315-133,208,606 |
ANXA10 |
annexin A10 |
11199 |
Q9UJ72 |
chr4: 168,092,515-168,187,690 |
CDH22 |
cadherin 22, type 2 |
64405 |
Q9UJ99 |
chr20: 46,173,733-46,308,498 |
SLC25A13 |
solute carrier family 25 (aspartate/glutamate carrier), member 13 |
10165 |
Q9UJS0 |
chr7: 96,120,220-96,322,147 |
MAN1B1 |
mannosidase, alpha, class 1B, member 1 |
11253 |
Q9UKM7 |
chr9: 137,086,927-137,109,187 |
NRXN1 |
neurexin 1 |
9378 |
Q9ULB1 |
chr2: 49,918,505-51,225,575 |
HEG1 |
heart development protein with EGF-like domains 1 |
57493 |
Q9ULI3 |
chr3: 124,965,710-125,055,958 |
PADI4 |
peptidyl arginine deiminase, type IV |
23569 |
Q9UM07 |
chr1: 17,308,195-17,364,004 |
HPCAL4 |
hippocalcin like 4 |
51440 |
Q9UM19 |
chr1: 39,678,648-39,691,689 |
EPDR1 |
ependymin related 1 |
54749 |
Q9UM22 |
chr7: 37,683,843-37,951,941 |
GUCA1B |
guanylate cyclase activator 1B |
2979 |
Q9UMX6 |
chr6: 42,184,401-42,194,916 |
PCDHGC3 |
protocadherin gamma subfamily C, 3 |
5098 |
Q9UN70 |
chr5: 141,475,947-141,512,979 |
PCDHA7 |
protocadherin alpha 7 |
56141 |
Q9UN72 |
chr5: 140,834,248-141,012,344 |
PCDHA6 |
protocadherin alpha 6 |
56142 |
Q9UN73 |
chr5: 140,827,958-141,012,344 |
PCDHA4 |
protocadherin alpha 4 |
56144 |
Q9UN74 |
chr5: 140,806,929-141,012,344 |
PCDHA12 |
protocadherin alpha 12 |
56137 |
Q9UN75 |
chr5: 140,875,302-141,012,344 |
RPH3AL |
rabphilin 3A-like (without C2 domains) |
9501 |
Q9UNE2 |
chr17: 212,389-386,254 |
MACF1 |
microtubule-actin crosslinking factor 1 |
23499 |
Q9UPN3 |
chr1: 39,081,316-39,487,177 |
MYO5A |
myosin VA |
4644 |
Q9Y4I1 |
chr15: 52,307,283-52,529,050 |
PCDHB9 |
protocadherin beta 9 |
56127 |
Q9Y5E1 |
chr5: 141,187,127-141,191,541 |
PCDHB3 |
protocadherin beta 3 |
56132 |
Q9Y5E6 |
chr5: 141,100,473-141,103,827 |
PCDHB14 |
protocadherin beta 14 |
56122 |
Q9Y5E9 |
chr5: 141,222,932-141,227,759 |
PCDHA9 |
protocadherin alpha 9 |
9752 |
Q9Y5H5 |
chr5: 140,847,463-141,012,344 |
PCDHA8 |
protocadherin alpha 8 |
56140 |
Q9Y5H6 |
chr5: 140,841,187-141,012,344 |
PCDHA5 |
protocadherin alpha 5 |
56143 |
Q9Y5H7 |
chr5: 140,821,604-141,012,344 |
PCDHA3 |
protocadherin alpha 3 |
56145 |
Q9Y5H8 |
chr5: 140,801,028-141,012,344 |
PCDHA2 |
protocadherin alpha 2 |
56146 |
Q9Y5H9 |
chr5: 140,794,852-141,012,344 |
PCDHA13 |
protocadherin alpha 13 |
56136 |
Q9Y5I0 |
chr5: 140,882,208-141,012,344 |
PCDHA11 |
protocadherin alpha 11 |
56138 |
Q9Y5I1 |
chr5: 140,868,183-141,012,344 |
PCDHA10 |
protocadherin alpha 10 |
56139 |
Q9Y5I2 |
chr5: 140,855,883-141,012,344 |
PCDHA1 |
protocadherin alpha 1 |
56147 |
Q9Y5I3 |
chr5: 140,786,136-141,012,347 |
PCDHAC2 |
protocadherin alpha subfamily C, 2 |
56134 |
Q9Y5I4 |
chr5: 140,966,235-141,012,344 |
MMP24 |
matrix metallopeptidase 24 |
10893 |
Q9Y5R2 |
chr20: 35,226,654-35,277,000 |
FKBP7 |
FK506 binding protein 7 |
51661 |
Q9Y680 |
chr2: 178,463,664-178,478,600 |
PCLO |
piccolo presynaptic cytomatrix protein |
27445 |
Q9Y6V0 |
chr7: 82,754,013-83,162,930 |